Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Olfactory receptor 6N1 (OR6N1) is a member of the olfactory receptor family and is responsible for the detection of odorant molecules in the nose, initiating the neuronal responses that enable the perception of smell[1][3][5][10]. OR6N1, like other olfactory receptors, is a G protein-coupled receptor (GPCR) with a characteristic 7-transmembrane domain structure and participates in G protein-mediated signal transduction following binding to specific odorants[1][2][3][5]. The olfactory receptor gene family is the largest in the human genome, and these genes are primarily expressed in the olfactory epithelium, though recent research indicates possible roles in some extranasal tissues[1][6]. OR6N1 is not generally recognized as a therapeutic drug target and currently lacks known pharmacological ligands or established mechanisms of drug action[1][5][6][10]. There is limited evidence linking this receptor to disease, with rare mention of associations such as entropion, but its canonical biological function remains sensory detection of odors[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Olfactory receptor 6N1 (OR6N1).